PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Baylis Medical Company Inc.

USPTO PatentsView assignee record - 49 granted patents across 6 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Baylis ranks #6,741 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 6 technology areas.

#6,741
of 49,997 US assignees by volume
46th percentile
by Innovation Score (33.8/100)
13.7
avg claims per patent
+58%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6741 · Foreign Corporation #6,741 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 49 grants
  • UPPER-Q #6,741/49,997
  • PHOTO-FINISH Bath & Body Works…
  • CPC-NARROW A61B · 6 areas
  • INNOV-THIN 33.8/100
  • CLAIMS-RICH 13.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +58% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bath & Body Works Brand Management, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Baylis’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Baylis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Baylis's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Baylis?

Each dot is one of Baylis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Baylis’s own 13.7 claims/patent is at or below the 15.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Baylis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 48.949.049.04949.049.049.1 0510152025 Granted patents (volume) Avg claims / patent Brose Fahrzeugteile SE & Co. Kommanditgesellschaft, Coburg - 49, 18.55Brose Fahrzeugtei…Bath & Body Works Brand Management, Inc. - 49, 1Bath & Body Works…Bavarian Nordic A/S - 49, 15.67Bavarian Nordic A…Baxter Corporation Englewood - 49, 19.59Baxter EnglewoodBioVentrix, Inc. - 49, 16.9BioventrixBromium, Inc. - 49, 21.67BromiumC-Smartlink Information Technology Co., Ltd. - 49, 1.63C-smartlink Infor…Cal-comp BIG Data, Inc. - 49, 11.02Cal-comp BIG DataBaylis Medical Company Inc. - 49, 13.65Baylis Medical
Baylis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Baylis's grants concentrate

Baylis Medical Company Inc. is a focused PatentsView assignee: 6 CPC subclasses with 67.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (13 grants) versus a trough of 1 in 2018. By volume, Baylis sits between Brose Fahrzeugteile SE & Co. Kommanditgesellschaft, Coburg and Cal-comp BIG Data, Inc..

Baylis's three-year grant acceleration

From 2019–2021 to 2022–2024, Baylis Medical Company Inc. moved from 25 to 13 grants (0.52x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Baylis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Baylis holds 49 patents at rank #6,745, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Baylis

By rank, the assignees closest to #6,745 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Baylis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Baylis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Baylis ranks #577 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

RH US, LLC 34 Shuffle Master GmbH & Co KG 34 HCT Group Holdings Limited 34 ratiopharm GmbH 34

Baylis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022 13
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Baylis Medical Company Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 6.1%
2016 5 10.2%
2017 2 4.1%
2018 1 2.0%
2019 8 16.3%
2020 10 20.4%
2021 7 14.3%
2022 13 26.5%

Which technologies does Baylis Medical Company Inc. patent most?

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Baylis Medical Company Inc.'s patent record in context - here's where to go next.

  • Baylis Medical Company Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 67.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #6,741 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Baylis Medical Company Inc. against Brose Fahrzeugteile SE & Co. Kommanditgesellschaft, Coburg, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.